Efficacy and safety of third-generation full length recombinant human coagulation factor Ⅷ in the prophylactic treatment of childhood patients with moderate-to-severe hemophilia A: A single center experience

doi:10.19538/j.ek2017010616

Home>Articles>Efficacy and safety of third-generation full length recombinant human coagulation factor Ⅷ in the prophylactic treatment of childhood patients with moderate-to-severe hemophilia A: A single center experience

DOI: 10.19538/j.ek2017010616

Efficacy and safety of third-generation full length recombinant human coagulation factor Ⅷ in the prophylactic treatment of childhood patients with moderate-to-severe hemophilia A: A single center experience

Keywords：hemophilia Aprophylactic treatmentrecombinant human coagulation factor ⅧADVATE

Publication Date：2017-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Chinese Journal of Practical Pediatrics

PKUISTIC

ISSN：1003-9996

Year, Vol.(Issue)：2017,32(1)